Akron Pharma, Inc.: Drug Recall
Recall #D-0454-2023 · 02/17/2023
Class III: Low Risk
Recall Details
- Recall Number
- D-0454-2023
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Akron Pharma, Inc.
- Status
- Terminated
- Date Initiated
- 02/17/2023
- Location
- Fairfield, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,416 tubes
Reason for Recall
Labeling: Incorrect or Missing Lot and/or Exp Date
Product Description
DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1
Distribution Pattern
Nationwide within the United States
Other Recalls by Akron Pharma, Inc.
- Class III: Low Risk 12/12/2024
- Class III: Low Risk 12/12/2024
- Class III: Low Risk 12/12/2024
- Class III: Low Risk 12/12/2024
- Class III: Low Risk 12/12/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.